Bio Financial Statements From 2010 to 2024
| TECH Stock | USD 71.28 0.23 0.32% |
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
Bio |
Bio Techne Corp Company Return On Equity Analysis
Bio Techne's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Bio Techne Return On Equity | 0.0729 |
Most of Bio Techne's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Techne Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Bio Techne Corp has a Return On Equity of 0.0729. This is 100.3% lower than that of the Life Sciences Tools & Services sector and 100.2% lower than that of the Health Care industry. The return on equity for all United States stocks is 123.52% lower than that of the firm.
Bio Techne Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio Techne's current stock value. Our valuation model uses many indicators to compare Bio Techne value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Techne competition to find correlations between indicators driving Bio Techne's intrinsic value. More Info.Bio Techne Corp is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.76 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bio Techne Corp is roughly 1.31 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Techne's earnings, one of the primary drivers of an investment's value.About Bio Techne Financial Statements
Investors use fundamental indicators, such as Bio Techne's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. Bio-Techne operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3000 people.
Currently Active Assets on Macroaxis
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:Check out the analysis of Bio Techne Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.